-We also did some deep mutational scanning on DNAJB6 and identified variants with enhanced activity!
-Really couldn't have done this without our collaborators! This project has been on my mind daily for many many years and I'm very pleased to be able to share it
My second paper from grad school! We worked with Peter St George-Hyslop, Gabriele Kaminski Schierle (@mng_ceb), and the @RuggeriLab
A multiplex platform to identify mechanisms and modulators of proteotoxicity in neurodegeneration https://t.co/rKgAxBBduF
-We identified DNAJB6 as a chaperone with activity against multiple ALS/FTD associated models including TDP-43, FUS, and hnRNPA1 in both yeast and mammalian cell culture
-We showed with multiple in vitro techniques that DNAJB6 modulates FUS's propensity to aggregate
If your lab has 293T cells, crystal violet, and a plate reader, you can do this assay! It's reporter-free, transfection-based, and robust to protocol variation. We hope this assay will expedite therapeutic identification and will be highly useful in the case of future pandemics
My first publication from grad school! In collaboration with the David Ho and Brent Stockwell labs, we developed a simple cell culture-based assay to identify protease inhibitors targeted at SARS-CoV-2 and other coronaviruses #COVID19 https://t.co/JvPfOTcttQ
The assay we developed works well for numerous coronavirus proteases and many known protease inhibitors. We get potency data highly similar to data produced from live virus assays. We can identify compounds that are broadly active against strains with the ability to infect humans
Our newest manuscript is live on bioRxiv! Beautiful work led by Leo @Vopinator in the lab, for high-efficiency, multiplexed DNA insertions in bacteria using CRISPR RNA-guided integrases. A great collaboration w/ @RondaCarlotta and @harriswangnyc. 1/n
https://t.co/be90twd2Rw